National Healthcare Corp Files 8-K
Ticker: NHC · Form: 8-K · Filed: Aug 6, 2024 · CIK: 1047335
Sentiment: neutral
Topics: material-definitive-agreement, acquisition-disposition, regulation-fd
TL;DR
NHC filed an 8-K on 7/31/24 for a material definitive agreement and asset acquisition/disposition.
AI Summary
On July 31, 2024, National Healthcare Corporation (NHC) entered into a Material Definitive Agreement related to the completion of an acquisition or disposition of assets. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for National Healthcare Corporation, potentially involving asset changes or acquisitions that could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements and asset acquisitions/dispositions can introduce significant financial and operational risks.
Key Numbers
- 001-13489 — SEC File Number (Identifies the specific SEC filing for National Healthcare Corporation.)
- 52-2057472 — I.R.S. Employer Identification No. (Tax identification number for National Healthcare Corporation.)
Key Players & Entities
- NATIONAL HEALTHCARE CORP (company) — Registrant
- July 31, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 100 Vine Street Murfreesboro, Tennessee 37130 (address) — Principal Executive Offices
- (615) 890-2020 (phone_number) — Registrant's telephone number
FAQ
What specific type of material definitive agreement was entered into by National Healthcare Corporation?
The filing indicates the entry into a Material Definitive Agreement related to the 'Completion of Acquisition or Disposition of Assets' as of July 31, 2024.
What is the primary business of National Healthcare Corporation?
National Healthcare Corporation operates in the 'SERVICES-SKILLED NURSING CARE FACILITIES' sector, as indicated by its Standard Industrial Classification code [8051].
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on August 6, 2024.
Where are National Healthcare Corporation's principal executive offices located?
The principal executive offices are located at 100 Vine Street, Murfreesboro, Tennessee 37130.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 31, 2024.
Filing Stats: 1,257 words · 5 min read · ~4 pages · Grade level 11.8 · Accepted 2024-08-06 15:50:05
Key Financial Figures
- $0.1 — nge on which registered Common Stock , $0.1 par value NHC NYSE American Indicat
- $200,000,000 — ). The Credit Agreement provides for a $200,000,000 senior credit facility with a five-year
- $50,000,000 — y with a five-year term consisting of a $50,000,000 revolving facility and a $150,000,000 t
- $150,000,000 — a $50,000,000 revolving facility and a $150,000,000 term facility (the "Credit Facility").
- $221,400,000.00 — ur Hundred Thousand and 00/100 Dollars ($221,400,000.00), subject to prorations and adjustments
Filing Documents
- nhc20240806_8k.htm (8-K) — 35KB
- ex_709417.htm (EX-99.1) — 7KB
- 0001437749-24-024854.txt ( ) — 177KB
- nhc-20240731.xsd (EX-101.SCH) — 3KB
- nhc-20240731_def.xml (EX-101.DEF) — 11KB
- nhc-20240731_lab.xml (EX-101.LAB) — 15KB
- nhc-20240731_pre.xml (EX-101.PRE) — 11KB
- nhc20240806_8k_htm.xml (XML) — 3KB
01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On August 1, 2024, National HealthCare Corporation ("NHC"), as Borrower, and certain of its subsidiaries, as Guarantors, entered into a Credit Agreement (the "Credit Agreement") with Bank of America, N.A., as lender (the "Lender"). The Credit Agreement provides for a $200,000,000 senior credit facility with a five-year term consisting of a $50,000,000 revolving facility and a $150,000,000 term facility (the "Credit Facility"). The Credit Facility is for general corporate purposes, including working capital and acquisitions. NHC is permitted, upon required notice to Lender and subject to certain minimum prepayment amounts, to prepay the amounts outstanding under the Credit Facility at any time without penalty. The unutilized portion of the commitments under the Credit Facility may be irrevocably reduced or terminated by NHC at any time. Loans bear interest at either (i) Term SOFR for interest periods of one (1), three (3) or six (6) months, plus the applicable margin or, at NHC's option, (ii) the Base Rate plus the applicable margin. The applicable margin is a rate per annum between 1.30% and 1.65% for Term SOFR loans and between .30% and .65% for Base Rate loans, depending upon NHC meeting certain conditions. NHC's obligations under the Credit Agreement are unsecured. The Credit Agreement contains customary representations and warranties, financial covenants, and other customary affirmative and negative covenants. The Credit Agreement also contains customary events of default. The description of the terms of the Credit Agreement contained in this Item 1.01 is qualified in its entirety by reference to the full text of the Credit Agreement, a copy of which NHC will file as an exhibit to the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2024.
01. COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS
ITEM 2.01. COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS. NHC announced that on July 31, 2024 it completed the previously announced acquisition of fourteen skilled nursing facilities, which includes five facilities in North Carolina (three of which are continuing care retirement communities), and nine facilities in South Carolina, the assignment of a lease agreement for one skilled nursing facility under lease with White Oak of Waxhaw, LLC in North Carolina (the "White Oak Senior Care Business"), and the purchase of the White Oak long term care pharmacy domiciled in South Carolina and licensed in both North Carolina and South Carolina (the "Transaction"), effective August 1, 2024. The acquisition was effectuated pursuant to a Purchase and Sale Agreement entered on May 31, 2024 (the "Agreement") by and between NHC/OP, L.P., a subsidiary of NHC, and White Oak Manor, Inc., a South Carolina corporation, its corporate subsidiaries, and White Oak Pharmacy, Inc., a South Carolina corporation, along with Douglas M. Cecil, Oliver K. Cecil, Jr., Dorothy Dean Cecil, Jeni Cecil Feeser, Beth Creech Cecil, John P. Barber and Teresa J. Cecil, as Trustee of the Teresa J. Cecil Revocable Trust U/A (collectively, the "Seller Parties" or "White Oak"), the entry of which was previously reported on a Form 8-K filed on May 31, 2024. NHC also entered a lease for the White Oak home office building in Spartanburg, South Carolina. The purchase price for the Transaction was Two Hundred Twenty-One Million Four Hundred Thousand and 00/100 Dollars ($221,400,000.00), subject to prorations and adjustments as set forth in the Agreement. NHC purchased the name "White Oak," and derivations thereof, including any logos and trademarks and will initially operate the facilities under the White Oak name. The description of the terms of the Agreement and acquisition contained in this Item 2.01 is qualified in its entirety by reference to the full text of the Agreement, a copy of which NHC will fil
01 REGULATION FD DISCLOSURE
Item 7.01 REGULATION FD DISCLOSURE On August 6, 2024, NHC issued a press release announcing its completion of the asset acquisition of the White Oak Senior Care Business and White Oak long term care pharmacy. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Number Exhibit 99.1 Press release dated August 6, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 6, 2024 NATIONAL HEALTHCARE CORPORATION By: /s/Stephen F. Flatt Name: Stephen F. Flatt Title: CEO